Every major player in your health system gets a direct line to the industry’s most-needed insights and
the support to take action. Learn about our research platform.
A strategic focus on talent is critical to success. Learn how we can help you make the right investments.
Attract and retain the patients you aspire to serve by offering the care network, access, and experience they need. See a list of our capabilities below or visit the Optum website for more information about our comprehensive approach to health care operations.
Improve quality and outcomes and lower costs by eliminating unwarranted deviation from the best standard of care. See a list of our capabilities below or visit the Optum website for more information about our comprehensive approach to data and analytics.
Sustain the financial stability to serve your community by making sure you’re paid efficiently for services rendered. See a list of our capabilities below or visit the Optum website for more information about our comprehensive approach to revenue cycle management.
Make sure every level of your organization understands best practice performance and has the tools
and support to get there. Learn about our research platform.
Pinpoint your opportunities and hardwire best practices to accelerate progress. Learn about our technology.
Partner with seasoned experts providing strategic, customized support. Learn about our consulting services.
Deirdre has been a researcher at The Advisory Board Company since 2012.
During her tenure with the Oncology Roundtable, Deirdre has contributed to research on payment reform, patient-centered care, growth strategy, physician alignment, clinical trial accrual, population health, and financial navigation.
Deirdre received her PhD in Immunology from Duke University. She received her undergraduate degree summa cum laude from the College of William and Mary.
Service Line Growth,
Get strategies to reduce non-value-added care in oncology, an update on clinical pathway adoption and effective use, and guidance on developing pathways that encompass the entire continuum of care. More
When FDA approved two CAR-T cell therapies last year, it caused a groundswell of excitement across the country—but many questions remain around implementation and reimbursement. Keep reading to learn how one leading cancer center has reorganized its services to improve care for immunotherapy patients and how barriers to reimbursement are raising concerns about access. More
Learn about new innovations in radiation oncology and how to position your program for success by revamping your investment strategy, finding opportunities to reduce costs, and prioritizing patient preferences.